Cancer medicines

Isatuximab

Isatuximab

A CD38-targeting antibody used in myeloma combinations.

Sources checked · Introductory guide

On this page

How it works

It binds CD38 to promote immune-mediated and direct cancer cell death.[3]

Where it is used

Used in selected myeloma combinations with pomalidomide, carfilzomib or other medicines according to prior therapy and transplant eligibility.[1]

Key safety points

Monitor infusion reactions, infection and cytopenias. It can affect compatibility testing; confirm pretreatment tests and disclose use before transfusion.[2]

Questions for your care team

  • How are combination medicines, infection prevention and transfusion testing arranged?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Isatuximab-irfc (opens in a new tab)
  2. MedlinePlus · Isatuximab-irfc (opens in a new tab)
  3. NCI Drug Dictionary · Isatuximab-irfc (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Isatuximab | Cancer Encyclopedia | My Chemo Diary